Sep 4, 2021

Pharmaxis wound and scar treatment clears phase one trial

Posted by in category: biotech/medical

(ASX: PXS) has announced that its novel topical drug treatment for scarring has delivered positive phase one clinical trial results and will now advance to the next stage of development in patients.

Leave a reply